Compare GSL & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSL | SNY |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | Greece | France |
| Employees | 7 | 74846 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 104.5B |
| IPO Year | N/A | N/A |
| Metric | GSL | SNY |
|---|---|---|
| Price | $39.77 | $44.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $44.00 | ★ $58.00 |
| AVG Volume (30 Days) | 350.1K | ★ 2.3M |
| Earning Date | 05-18-2026 | 04-23-2026 |
| Dividend Yield | ★ 6.34% | 3.47% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.49 |
| Revenue Next Year | N/A | $6.10 |
| P/E Ratio | ★ $3.49 | $6.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.45 | $42.28 |
| 52 Week High | $42.70 | $52.68 |
| Indicator | GSL | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 56.34 | 50.79 |
| Support Level | $36.97 | $43.32 |
| Resistance Level | $39.91 | $45.18 |
| Average True Range (ATR) | 1.08 | 0.57 |
| MACD | 0.16 | 0.14 |
| Stochastic Oscillator | 94.09 | 68.58 |
Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.